Check out your Company Bowl for anonymous work chats.
Could your ideas make headlines? The race to cure life-threatening diseases is on. Passionate research teams around the world tirelessly work towards the discovery of new treatments for cancer, inheritable diseases or future pandemics. Sartorius is at their side, equipping them with cutting-edge technologies that help translate scientific discoveries into effective therapies more quickly – so that patients get the treatments they need. We're in this together. Let's team up to shape tomorrow’s biopharma solutions. We’re ready for your big ideas at https://lnkd.in/ed_dEEUi
The life science group Sartorius has released its Annual Report for 2023 today. 📒
Your work in life science is as complex as it gets? Behind every scientific breakthrough is more than just data, statistics and results. It's the scientists whose curiosity, creativity and tenacity are the driving force behind this progress. Never alone, but with a partner they trust. At Sartorius, we understand the challenges and opportunities that our partners face, from research to drug development to production. And we'll work with them to help make their work easier by asking: How can we make it simpler for them? We’re in this together. We simplify the complex to make your work easier. www.sartorius.com/inthistogether
Attention job seekers! Are you ready to take a peek at the opportunities that are ahead of you? Sartorius is looking for ambitious experts who want to advance their careers in Germany, India, the U.S. and elsewhere Join us in Sales, Services, R&D, and other functions and become part of the solution in accelerating the development and production of breakthrough therapies. Find your fit at www.sartorius.com/careers
Sartorius expects profitable growth in 2024 “2023 was a very unusual and challenging year for our industry. Customer destocking and other factors had a longer and more pronounced impact on the business than initially anticipated. We therefore ended the year with a decline in sales revenue, while profitability remained at a healthy level and above the pre-pandemic mark due to an adjusted cost base. Many customers are further advanced in optimizing their inventories. Business has thus picked up since the third quarter, and we expect this trend to gradually intensify in the course of 2024,” said CEO Joachim Kreuzburg. ➡️ Preliminary 2023 results in line with forecast ➡️ Demand recovery in both divisions in the fourth quarter ➡️ 2024 guidance: group expects profitable growth ➡️ Investment in innovation, customer proximity, resilience, sustainability ➡️ 2028 ambition: average annual sales revenue increase of more than 10%, profit margin to increase to ~34% Read media release: https://srtrs.info/tv3j8
Need to find the one promising drug candidate out of 10,000? Getting there is a daunting journey, involving thousands of experiments, sample preparation procedures and analyses. With innovative tools, technologies, and services, Sartorius enables scientists to simplify workflows, minimize human errors and ultimately accelerate their research to get to the finishing line more efficiently. We’re in this together. We have the solutions to find the most promising drug candidate faster. Explore our drug discovery options at https://www.sartorius.com/inthistogether
The complexity of drug discovery, especially with the advent of 3D cell culture systems and cell and gene therapies, presents new challenges. Sartorius addresses these by asking: “How can we make it simpler?” – a question that reflects our approach to accelerating the development and production of new medicines. The vision for an integrated end-to-end solution, says René Fáber, Head of Bioprocess Solutions at Sartorius, is: “You just put your cell culture vessels inside a robot, push the button, and run 24 experiments in a week instead of 12 in three months – and that’s a realistic expectation of what our systems can bring to clients.” Read more about where our heads of division, René Fáber and Alexandra Gatzemeyer, one of the founders of CellGenix, Felicia Rosenthal, and our Head of Product Development Lab Products & Solutions, Thomas Duensing, see these innovations going in Science magazine: https://ow.ly/YOTk50QpQ2w
Hovery Yin planned to pursue a technical career until an opportunity in project management at Sartorius arose. Today, he leads the project management team for Filtration & Single Use Solutions at the Sartorius Confidence® Validation Services China, ensuring that biopharmaceutical manufacturers can develop and produce safe drugs and therapies for patients worldwide. Learn more about his journey from technical expert to project manager on the Sartorius Blog: https://ow.ly/vQN350QnK1N
Could your ideas make headlines? Scientists around the globe put their minds and hearts into exploring better therapies, to find new solutions against cancer, inheritable diseases, and future pandemics. Sartorius stands shoulder to shoulder with researchers, providing cutting-edge technologies that help to translate their scientific discoveries into effective patient care faster. We're in this together. Let's team up to shape tomorrow’s biopharma solutions. We’re ready for your big ideas at www.sartorius.com/inthistogether
Are you ready to fulfil your New Year's resolutions and advance your career? Then this is your sign. Visit www.sartorius.com/careers, find your new job and grow professionally in the dynamic life science environment.
